The Library
Prevalence and risk factors of albuminuria in Type 2 diabetes in Bahrain
Tools
Al-Salman, R. A., Al-Basri, H. A., Al-Sayyad, A. S. and Hearnshaw, Hilary (2009) Prevalence and risk factors of albuminuria in Type 2 diabetes in Bahrain. Journal of Endocrinological Investigation, Vol.32 (No.9). pp. 746-751. ISSN 0391-4097.
Research output not available from this repository.
Request-a-Copy directly from author or use local Library Get it For Me service.
Official URL: http://www.jendocrinolinvest.it/jei/en/sommario.cf...
Abstract
Microalbuminuria is the earliest sign of diabetic nephropathy, and is a marker of increased diabetic cardiovascular morbidity and mortality. We investigated the prevalence of albuminuria and associated risk factors among Type 2 diabetes (T2DM) patients, who were attending diabetes clinics at primary healthcare facilities in Bahrain. This was a cross-sectional study on 712 adult T2DM Bahraini patients screened for albuminuria using albumin:creatinine ratio test (ACR), in 9 selected primary healthcare centers in Bahrain in the period February-March 2006. Of the 702 participants, 196 (27.9%) were albuminuric. The prevalence of microalbuminuria (ACR>3.4 mg albumin/mmol creatinine) and macroalbuminuria (protein:creatinine ratio >22 mg protein/mmol creatinine) were 22.0% (no.=155) and 5.8% (no.=41), respectively. Univariate analysis demonstrated significant associations between albuminuria and older age (>65 yr), longer duration of diabetes, high glycated hemoglobin (HbA(1c)), elevated triglycerides, total- and LDL-cholesterol, systolic (>160 mmHg) and diastolic (>90 mmHg) blood pressure (BP), and retinopathy. Multivariate regression analysis showed that high HbA(1c), higher systolic BP, and long duration of diabetes, were significant predictors of albuminuria, while older age, male gender, and higher triglycerides were borderline predictors. Albuminuria in Bahraini T2DM patients was related to poor glycemic control, higher systolic BP, and longer duration of diabetes. Effective preventive and control strategies of those factors should be urgently implemented. (J. Endocrinol. Invest. 32: 746-751, 2009) (C) 2009, Editrice Kurtis
Item Type: | Journal Article | ||||
---|---|---|---|---|---|
Subjects: | R Medicine > RC Internal medicine | ||||
Divisions: | Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School | ||||
Journal or Publication Title: | Journal of Endocrinological Investigation | ||||
Publisher: | Editrice Kurtis s.r.l. | ||||
ISSN: | 0391-4097 | ||||
Official Date: | October 2009 | ||||
Dates: |
|
||||
Volume: | Vol.32 | ||||
Number: | No.9 | ||||
Number of Pages: | 6 | ||||
Page Range: | pp. 746-751 | ||||
Status: | Peer Reviewed | ||||
Publication Status: | Published | ||||
Access rights to Published version: | Restricted or Subscription Access |
Data sourced from Thomson Reuters' Web of Knowledge
Request changes or add full text files to a record
Repository staff actions (login required)
View Item |